Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
Top Cited Papers
Open Access
- 29 July 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 11 (7), e1001685
- https://doi.org/10.1371/journal.pmed.1001685
Abstract
Mary Hamel and colleagues in the RTS,S Clinical Trials Partnership report updated safety and efficacy results from an ongoing Phase 3 trial, including calculations of vaccine impact (malaria cases prevented). Please see later in the article for the Editors' SummaryKeywords
This publication has 31 references indexed in Scilit:
- The changing risk of Plasmodium falciparum malaria infection in Africa: 2000–10: a spatial and temporal analysis of transmission intensityThe Lancet, 2014
- High level of resistance in the mosquito Anopheles gambiae to pyrethroid insecticides and reduced susceptibility to bendiocarb in north-western TanzaniaMalaria Journal, 2013
- Estimates of child deaths prevented from malaria prevention scale-up in Africa 2001-2010Malaria Journal, 2012
- Global malaria mortality between 1980 and 2010: a systematic analysisThe Lancet, 2012
- Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of ProtectionThe Journal of Infectious Diseases, 2009
- Artemisinin Resistance inPlasmodium falciparumMalariaThe New England Journal of Medicine, 2009
- Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in InfantsThe New England Journal of Medicine, 2008
- Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trialThe Lancet, 2007
- Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trialThe Lancet, 2001
- A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine againstPlasmodium falciparumMalariaNew England Journal of Medicine, 1997